RecruitingPHASE2, PHASE3NCT04297683
HEALEY ALS Platform Trial - Master Protocol
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Merit E. Cudkowicz, MD
- Principal Investigator
- Merit Cudkowicz, MDMassachusetts General Hospital
- Intervention
- Zilucoplan(drug)
- Enrollment
- 1500 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2020 – 2028
Study locations (30)
- Barrow Neurological Institute, Phoenix, Arizona, United States
- Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Loma Linda University Health, Loma Linda, California, United States
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
- University of Southern California, Los Angeles, California, United States
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- University of California, Irvine, Orange, California, United States
- Forbes Norris MDA/ALS Research Center, California Pacific Medical Center, San Francisco, California, United States
- University of California, San Francisco, San Francisco, California, United States
- University of Colorado, Aurora, Colorado, United States
- Hospital for Special Care, New Britain, Connecticut, United States
- Yale University, New Haven, Connecticut, United States
- Georgetown University, Washington D.C., District of Columbia, United States
- George Washington University, Washington D.C., District of Columbia, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Massachusetts General Hospital
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04297683 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)